Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)
NCT00240877
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
330
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
AV024
OTHER:
Placebo
Sponsor
MedImmune LLC